These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30575522)

  • 1. Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ.
    Shang J; Brust R; Mosure SA; Bass J; Munoz-Tello P; Lin H; Hughes TS; Tang M; Ge Q; Kamenekca TM; Kojetin DJ
    Elife; 2018 Dec; 7():. PubMed ID: 30575522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping.
    Sheu SH; Kaya T; Waxman DJ; Vajda S
    Biochemistry; 2005 Feb; 44(4):1193-209. PubMed ID: 15667213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for differential activities of enantiomeric PPARγ agonists: Binding of S35 to the alternate site.
    Jang JY; Koh M; Bae H; An DR; Im HN; Kim HS; Yoon JY; Yoon HJ; Han BW; Park SB; Suh SW
    Biochim Biophys Acta Proteins Proteom; 2017 Jun; 1865(6):674-681. PubMed ID: 28342850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the interactions between Edaglitazone and Ciglitazone with PPARγ and their antiplatelet profile.
    Muñoz-Gutiérrez C; Sepúlveda C; Caballero J; Palomo I; Fuentes E
    Life Sci; 2017 Oct; 186():59-65. PubMed ID: 28757415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unanticipated mechanisms of covalent inhibitor and synthetic ligand cobinding to PPARγ.
    Shang J; Kojetin DJ
    bioRxiv; 2024 Sep; ():. PubMed ID: 38798544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural mechanism underlying ligand binding and activation of PPARγ.
    Shang J; Kojetin DJ
    Structure; 2021 Sep; 29(9):940-950.e4. PubMed ID: 33713599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
    Waku T; Shiraki T; Oyama T; Fujimoto Y; Maebara K; Kamiya N; Jingami H; Morikawa K
    J Mol Biol; 2009 Jan; 385(1):188-99. PubMed ID: 18977231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) γ activators and pan-PPAR partial agonists.
    Liberato MV; Nascimento AS; Ayers SD; Lin JZ; Cvoro A; Silveira RL; Martínez L; Souza PC; Saidemberg D; Deng T; Amato AA; Togashi M; Hsueh WA; Phillips K; Palma MS; Neves FA; Skaf MS; Webb P; Polikarpov I
    PLoS One; 2012; 7(5):e36297. PubMed ID: 22649490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of new interactions of glitazone's stereoisomers and the endogenous ligand 15d-PGJ2 on six different PPAR gamma proteins.
    Álvarez-Almazán S; Bello M; Tamay-Cach F; Martínez-Archundia M; Alemán-González-Duhart D; Correa-Basurto J; Mendieta-Wejebe JE
    Biochem Pharmacol; 2017 Oct; 142():168-193. PubMed ID: 28716729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nuclear receptor PPARγ individually responds to serotonin- and fatty acid-metabolites.
    Waku T; Shiraki T; Oyama T; Maebara K; Nakamori R; Morikawa K
    EMBO J; 2010 Oct; 29(19):3395-407. PubMed ID: 20717101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand and receptor dynamics contribute to the mechanism of graded PPARγ agonism.
    Hughes TS; Chalmers MJ; Novick S; Kuruvilla DS; Chang MR; Kamenecka TM; Rance M; Johnson BA; Burris TP; Griffin PR; Kojetin DJ
    Structure; 2012 Jan; 20(1):139-50. PubMed ID: 22244763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma (PPARγ) has multiple binding points that accommodate ligands in various conformations: Structurally similar PPARγ partial agonists bind to PPARγ LBD in different conformations.
    Ohashi M; Gamo K; Oyama T; Miyachi H
    Bioorg Med Chem Lett; 2015 Jul; 25(14):2758-62. PubMed ID: 26025876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Basis for the Enhanced Anti-Diabetic Efficacy of Lobeglitazone on PPARγ.
    Jang JY; Bae H; Lee YJ; Choi YI; Kim HJ; Park SB; Suh SW; Kim SW; Han BW
    Sci Rep; 2018 Jan; 8(1):31. PubMed ID: 29311579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into human peroxisome proliferator activated receptor delta (PPAR-delta) selective ligand binding.
    Batista FA; Trivella DB; Bernardes A; Gratieri J; Oliveira PS; Figueira AC; Webb P; Polikarpov I
    PLoS One; 2012; 7(5):e33643. PubMed ID: 22606221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative structural assessment of graded receptor agonism.
    Shang J; Brust R; Griffin PR; Kamenecka TM; Kojetin DJ
    Proc Natl Acad Sci U S A; 2019 Oct; 116(44):22179-22188. PubMed ID: 31611383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for the activation of PPARgamma by oxidized fatty acids.
    Itoh T; Fairall L; Amin K; Inaba Y; Szanto A; Balint BL; Nagy L; Yamamoto K; Schwabe JW
    Nat Struct Mol Biol; 2008 Sep; 15(9):924-31. PubMed ID: 19172745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligands for the Nuclear Peroxisome Proliferator-Activated Receptor Gamma.
    Sauer S
    Trends Pharmacol Sci; 2015 Oct; 36(10):688-704. PubMed ID: 26435213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators.
    Hamuro Y; Coales SJ; Morrow JA; Molnar KS; Tuske SJ; Southern MR; Griffin PR
    Protein Sci; 2006 Aug; 15(8):1883-92. PubMed ID: 16823031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative structure-activity relationship models with receptor-dependent descriptors for predicting peroxisome proliferator-activated receptor activities of thiazolidinedione and oxazolidinedione derivatives.
    Lather V; Kairys V; Fernandes MX
    Chem Biol Drug Des; 2009 Apr; 73(4):428-41. PubMed ID: 19243388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural review of PPARγ in complex with ligands: Cartesian- and dihedral angle principal component analyses of X-ray crystallographic data.
    Kaupang Å; Laitinen T; Poso A; Hansen TV
    Proteins; 2017 Sep; 85(9):1684-1698. PubMed ID: 28543443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.